Quality of life and psychological outcomes with albumin-bound paclitaxel-carboplatin versus solvent-based paclitaxel-carboplatin as first-line chemotherapy in stage IC-IV ovarian carcinoma.

Gynecol Oncol Rep · 2026 · PMC13382505 · PMID 42518872

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp = 0.001actually significant

Within-group improvements were highly significant in both groups (Group A, nab-paclitaxel: baseline vs 6 m p = 0.001, baseline vs 12 m p = 0.001, 6 m vs 12 m p = 0.001; Group B, sb-paclitaxel: baseline vs 6 m p = 0.001, baseline vs 12 m p = 0.001, 6 m vs 12 m p = 0.01).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.